Want to join the conversation?
Healthcare giant $JNJ reported a 2.4% decline in 4Q15 sales due to strong U.S. dollar, despite a rise in earnings. Net income rose to $3.22Bil or $1.15 per share from $2.52Bil or $0.89 per share last year. Sales fell to $17.81Bil from $18.25Bil. Adjusted EPS increased 5.1% to $1.44.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.